Major trial tests new drug to ease debilitating symptoms of rett syndrome
Disease control
Recruiting now
This study is testing an oral medication called Bionetide to see if it can improve symptoms and communication abilities in girls and women with Rett syndrome, a rare genetic neurological disorder. It is a Phase 3 trial enrolling 210 participants aged 5 to 20. Participants will be…
Phase: PHASE3 • Sponsor: Biomed Industries, Inc. • Aim: Disease control
Last updated Apr 20, 2026 16:18 UTC